217 related articles for article (PubMed ID: 8922580)
1. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients.
Ryley HC; Ojeniyi B; Høiby N; Weeks J
Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):755-8. PubMed ID: 8922580
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center.
Vu-Thien H; Moissenet D; Valcin M; Dulot C; Tournier G; Garbarg-Chenon A
Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):876-9. PubMed ID: 8997562
[TBL] [Abstract][Full Text] [Related]
3. Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran.
Dallal MM; Telefian CF; Hajia M; Kalantar E; Dehkharghani AR; Forushani AR; Khanbabaei Q; Mobarhan M; Farzami MR
J Prev Med Hyg; 2014 Mar; 55(1):27-30. PubMed ID: 25916029
[TBL] [Abstract][Full Text] [Related]
4. Use of pulsed-field gel electrophoresis in infection control issues concerning Burkholderia cepacia.
Jenney A; Liolios L; Spelman D; Russo P; Wilson J; Wesselingh S; Kotsimbos T
Infect Control Hosp Epidemiol; 2003 Aug; 24(8):624-6. PubMed ID: 12940588
[TBL] [Abstract][Full Text] [Related]
5. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages.
Agodi A; Barchitta M; Gianninò V; Collura A; Pensabene T; Garlaschi ML; Pasquarella C; Luzzaro F; Sinatra F; Mahenthiralingam E; Stefani S
J Hosp Infect; 2002 Mar; 50(3):188-95. PubMed ID: 11886194
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
[TBL] [Abstract][Full Text] [Related]
7. Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation.
Heath DG; Hohneker K; Carriker C; Smith K; Routh J; LiPuma JJ; Aris RM; Weber D; Gilligan PH
J Clin Microbiol; 2002 Apr; 40(4):1188-93. PubMed ID: 11923329
[TBL] [Abstract][Full Text] [Related]
8. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital.
Siddiqui AH; Mulligan ME; Mahenthiralingam E; Hebden J; Brewrink J; Qaiyumi S; Johnson JA; LiPuma JJ
Infect Control Hosp Epidemiol; 2001 Jul; 22(7):419-22. PubMed ID: 11583209
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.
Speert DP; Henry D; Vandamme P; Corey M; Mahenthiralingam E
Emerg Infect Dis; 2002 Feb; 8(2):181-7. PubMed ID: 11897071
[TBL] [Abstract][Full Text] [Related]
10. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection.
Bernhardt SA; Spilker T; Coffey T; LiPuma JJ
Clin Infect Dis; 2003 Sep; 37(6):780-5. PubMed ID: 12955638
[TBL] [Abstract][Full Text] [Related]
11. Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center.
Richau JA; Leitão JH; Correia M; Lito L; Salgado MJ; Barreto C; Cescutti P; Sá-Correia I
J Clin Microbiol; 2000 Apr; 38(4):1651-5. PubMed ID: 10747161
[TBL] [Abstract][Full Text] [Related]
12. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?
LiPuma JJ
Transpl Infect Dis; 2001 Sep; 3(3):149-60. PubMed ID: 11493397
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.
Segonds C; Chabanon G; Couetdic G; Michel-Briand Y; Bingen E
Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):841-2. PubMed ID: 8950569
[No Abstract] [Full Text] [Related]
14. Molecular epidemiology of Burkholderia cepacia in two Australian cystic fibrosis centres.
Paul ML; Pegler MA; Benn RA
J Hosp Infect; 1998 Jan; 38(1):19-26. PubMed ID: 9513065
[TBL] [Abstract][Full Text] [Related]
15. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
[TBL] [Abstract][Full Text] [Related]
16. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study.
Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G
Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098
[TBL] [Abstract][Full Text] [Related]
17. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.
Agodi A; Mahenthiralingam E; Barchitta M; Gianninò V; Sciacca A; Stefani S
J Clin Microbiol; 2001 Aug; 39(8):2891-6. PubMed ID: 11474009
[TBL] [Abstract][Full Text] [Related]
18. Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.
Cunha MV; Pinto-de-Oliveira A; Meirinhos-Soares L; Salgado MJ; Melo-Cristino J; Correia S; Barreto C; Sá-Correia I
J Clin Microbiol; 2007 May; 45(5):1628-33. PubMed ID: 17360834
[TBL] [Abstract][Full Text] [Related]
19. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
Segonds C; Chabanon G
Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.
Mahenthiralingam E; Campbell ME; Henry DA; Speert DP
J Clin Microbiol; 1996 Dec; 34(12):2914-20. PubMed ID: 8940422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
